Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free BNTC Stock Alerts

Benitec Biopharma (BNTC) Short Interest Ratio & Short Volume

Benitec Biopharma logo
$11.60 +0.15 (+1.31%)
Closing price 04:00 PM Eastern
Extended Trading
$11.60 +0.00 (+0.01%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Benitec Biopharma Short Interest Overview

As of May 15, 2026, Benitec Biopharma (BNTC) had a short interest of 2.25 million shares sold short, representing 6.88% of the public float. This marks a -2.89% decrease in short interest since the prior report. The short interest ratio (days to cover) is 23.0, meaning it would take 23.0 days of the average trading volume of 87,798 shares to cover all short positions.

Current Short Interest
2,251,632 shares
Previous Short Interest
2,318,612 shares
Change Vs. Previous Month
-2.89%
Dollar Volume Sold Short
$25.87 million
Short Interest Ratio
23.0 Days to Cover
Last Record Date
May 15, 2026
Outstanding Shares
34,350,000 shares
Short Percent of Float
6.88%
Today's Trading Volume
57,567 shares
Average Trading Volume
87,798 shares
Today's Volume Vs. Average
66%
Short Selling Benitec Biopharma?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Benitec Biopharma and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BNTC Short Interest Over Time

BNTC Days to Cover Over Time

BNTC Percentage of Float Shorted Over Time

Benitec Biopharma Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20262,251,632 shares $25.87 million -2.9%6.9%22.99 $11.49
4/30/20262,318,612 shares $27.94 million +2.3%7.1%21.53 $12.05
4/15/20262,266,291 shares $30.82 million -1.7%6.9%21.61 $13.60
3/31/20262,305,987 shares $24.56 million +7.1%7.1%13.65 $10.65
3/13/20262,152,891 shares $25.30 million +6.7%6.6%8.35 $11.75
2/27/20262,018,595 shares $22.00 million -4.9%6.2%13.37 $10.90
2/13/20262,123,180 shares $22.04 million +1.5%6.5%16.37 $10.38
1/30/20262,091,235 shares $25.47 million +7.9%6.4%19.44 $12.18
1/15/20261,938,297 shares $22.70 million -1.3%6.0%13.3 $11.71
12/31/20251,963,460 shares $26.45 million +23.8%6.1%8.31 $13.47
12/15/20251,585,527 shares $19.31 million -4.5%4.9%5.67 $12.18
11/28/20251,660,549 shares $21.06 million +17.6%5.2%9.66 $12.69
11/14/20251,412,511 shares $18.59 million +22.4%5.7%2.83 $13.16
10/31/20251,153,794 shares $18.88 million +2.4%4.6%25.06 $16.36
10/15/20251,130,000 shares $17.97 million -14.4%4.5%22.7 $15.90
9/30/20251,320,000 shares $18.52 million +0.8%N/A23.1 $14.03
9/15/20251,310,000 shares $17.95 million -1.5%N/A13.3 $13.70
8/31/20251,330,000 shares $17.61 million -4.3%5.1%12.1 $13.24
8/15/20251,390,000 shares $18.08 million -2.8%N/A12.4 $13.01
7/31/20251,430,000 shares $15.63 million -0.7%5.5%12.8 $10.93
7/15/20251,440,000 shares $17.91 million +25.2%N/A13.2 $12.44
6/30/20251,150,000 shares $13.46 million +118.0%4.4%11.3 $11.70
6/15/2025527,600 shares $8.69 million +18.4%2.0%8.4 $16.48
5/31/2025445,600 shares $6.72 million +1.5%1.9%9 $15.07
5/15/2025439,200 shares $5.93 million +24.0%1.9%9.4 $13.50
4/30/2025354,100 shares $4.81 million +23.0%N/A8 $13.59
4/15/2025287,800 shares $3.94 million -2.2%1.2%6.9 $13.68
3/31/2025294,200 shares $3.83 million +36.1%1.3%7 $13.01
3/15/2025216,100 shares $3.24 million +23.6%0.9%4.3 $14.97
2/28/2025174,800 shares $2.22 million +17.6%0.8%3.5 $12.71
2/15/2025148,700 shares $1.67 million +16.2%0.6%2.9 $11.25
1/31/2025128,000 shares $1.47 million +3.1%N/A2.4 $11.49
1/15/2025124,100 shares $1.34 million +99.2%N/A2.4 $10.78
12/31/202462,300 shares $786.85 thousand +65.7%N/A1.1 $12.63
12/15/202437,600 shares $442.55 thousand +6.2%N/A0.7 $11.77
11/30/202435,400 shares $357.19 thousand +7.0%N/A0.9 $10.09
11/15/202433,100 shares $353.51 thousand -41.8%N/A1 $10.68
10/31/202456,900 shares $598.02 thousand +49.0%N/A2 $10.51
10/15/202438,200 shares $374.74 thousand -28.1%N/A1.3 $9.81
9/30/202453,100 shares $487.99 thousand -10.2%N/A2 $9.19
Goldman Sachs just told you what to buy (most people missed it) (Ad)

Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.tc pixel

See the stock positioned to solve AI's biggest power crisis
9/15/202459,100 shares $481.67 thousand -4.7%N/A2.6 $8.15
8/31/202462,000 shares $573.19 thousand -6.8%N/A2.1 $9.25
8/15/202466,500 shares $571.90 thousand -2.2%N/A2 $8.60
7/31/202468,000 shares $599.76 thousand -18.2%N/A1.8 $8.82
7/15/202483,100 shares $847.62 thousand -10.0%3.7%2 $10.20
6/30/202492,300 shares $645.18 thousand +871.6%4.1%0.9 $6.99
6/15/20249,500 shares $69.45 thousand -25.8%0.4%0.1 $7.31
5/31/202412,800 shares $97.92 thousand -77.2%0.6%0.1 $7.65
5/15/202456,100 shares $496.49 thousand -43.1%2.5%0.6 $8.85
4/30/202498,500 shares $832.33 thousand +707.4%6.3%1.2 $8.45
4/15/202412,200 shares $59.90 thousand +10.9%0.5%0.2 $4.91
3/31/202411,000 shares $57.75 thousand +115.7%0.5%0.7 $5.25
3/15/20245,100 shares $26.01 thousand -68.3%0.2%0.4 $5.10
2/29/202416,100 shares $78.09 thousand +151.6%0.7%1.1 $4.85
2/15/20246,400 shares $18.43 thousand -18.0%0.3%0.5 $2.88
1/31/20247,800 shares $21.92 thousand +25.8%0.3%0.9 $2.81
1/15/20246,200 shares $18.17 thousand -18.4%0.3%0.7 $2.93
12/31/20237,600 shares $24.55 thousand -39.7%0.3%0.7 $3.23
12/15/202312,600 shares $42.46 thousand +5.9%0.6%1.1 $3.37
11/30/202311,900 shares $37.84 thousand -64.4%0.5%0.8 $3.18
11/15/202333,400 shares $125.92 thousand -28.2%1.5%1.6 $3.77
10/31/202346,500 shares $167.87 thousand -20.7%3.1%0.6 $3.61
10/15/202358,600 shares $199.83 thousand -13.7%3.9%0.1 $3.41
9/30/202367,900 shares $205.17 thousand -24.7%4.6%0.1 $3.02
9/15/202390,200 shares $285.03 thousand -33.8%6.1%0.1 $3.16
8/31/2023136,300 shares $402.09 thousand -51.1%9.2%0.2 $2.95
8/15/2023278,500 shares $749.17 thousand +52.2%N/A0.4 $2.69
7/31/2023183,000 shares $563.64 thousand -81.2%N/A0.3 $3.08
7/15/2023974,300 shares $223.99 thousand -57.3%N/A0.3 $0.23
6/30/20232,280,000 shares $543.78 thousand +1,061.5%N/A0.7 $0.24
6/15/2023196,300 shares $46.11 thousand -22.8%N/A0.1 $0.23
5/31/2023254,300 shares $61.31 thousand -19.9%N/A0.9 $0.24
5/15/2023317,400 shares $67.86 thousand -5.8%N/A1.1 $0.21
4/30/2023337,000 shares $67.77 thousand +77.9%N/A1 $0.20
4/15/2023189,400 shares $40.44 thousand +73.4%N/A0.6 $0.21
3/31/2023109,200 shares $22.92 thousand -45.0%N/A0.4 $0.21
3/15/2023198,700 shares $46.69 thousand -52.5%N/A0.6 $0.24
2/28/2023418,700 shares $125.61 thousand +101.1%N/A0.9 $0.30
2/15/2023208,200 shares $47.76 thousand -3.6%N/A0.5 $0.23
1/31/2023215,900 shares $49.66 thousand -1.7%N/A0.5 $0.23
1/15/2023219,600 shares $50.93 thousand +109.9%N/A0.4 $0.23
12/30/2022104,600 shares $17.78 thousand +245.2%N/A0.2 $0.17
12/15/202230,300 shares $4.55 thousand -85.3%N/A0.1 $0.15
11/30/2022206,400 shares $42.31 thousand +24.9%N/A0.3 $0.21
11/15/2022165,200 shares $28.60 thousand -50.6%N/A0.3 $0.17
10/31/2022334,500 shares $58.64 thousand +310.4%4.5%0.6 $0.18
10/15/202281,500 shares $19.49 thousand -35.1%1.1%0.2 $0.24
9/30/2022125,600 shares $46.69 thousand +187.4%2.1%0.4 $0.37
9/15/202243,700 shares $18.75 thousand -87.7%0.6%0 $0.43
8/31/2022354,900 shares $262.52 thousand +26.8%5.0%0.2 $0.74
$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)

In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…tc pixel

Click here to watch this short 3-minute video now.
8/15/2022279,900 shares $236.53 thousand +353.7%4.0%0.1 $0.85
7/31/202261,700 shares $55.46 thousand -40.1%0.9%0 $0.90
7/15/2022103,000 shares $110.21 thousand -92.5%1.5%0 $1.07
6/30/20221,370,000 shares $1.59 million +13,738.4%19.5%0.6 $1.16
6/15/20229,900 shares $8.61 thousand +23.8%0.1%0 $0.87
5/31/20228,000 shares $8.40 thousand +281.0%0.1%0.3 $1.05
5/15/20222,100 shares $2.49 thousand -56.3%0.0%0.1 $1.18
4/30/20224,800 shares $7.20 thousand +166.7%0.1%0.2 $1.50
4/15/20221,800 shares $3.60 thousand -67.9%0.0%0.1 $2.00
3/31/20225,600 shares $13.08 thousand +75.0%0.1%0.2 $2.34
3/15/20223,200 shares $6.62 thousand -70.1%0.1%0.1 $2.07
2/28/202210,700 shares $24.82 thousand -17.1%0.2%0.3 $2.32
2/15/202212,900 shares $34.96 thousand +84.3%0.2%0.4 $2.71
1/31/20227,000 shares $17.15 thousand -77.4%0.1%0.2 $2.45
1/15/202231,000 shares $79.36 thousand +121.4%0.4%0.8 $2.56
12/31/202114,000 shares $36.68 thousand +17.7%0.2%0.4 $2.62
12/15/202111,900 shares $34.39 thousand -13.1%0.2%0.3 $2.89
11/30/202113,700 shares $41.92 thousand -9.3%0.2%0.1 $3.06
11/15/202115,100 shares $51.94 thousand -29.8%0.2%0.1 $3.44
10/29/202121,500 shares $78.69 thousand -21.3%0.3%0.2 $3.66
10/15/202127,300 shares $98.01 thousand -1.1%0.4%0.2 $3.59
9/30/202127,600 shares $98.53 thousand -78.0%0.4%0.2 $3.57
9/15/2021125,700 shares $487.72 thousand -19.5%1.9%0.7 $3.88
8/31/2021156,200 shares $618.55 thousand -25.1%3.9%1.5 $3.96
8/13/2021208,400 shares $827.35 thousand +7.1%5.2%2 $3.97
7/30/2021194,600 shares $681.10 thousand -2.5%4.9%0.7 $3.50
7/15/2021199,500 shares $758.10 thousand -14.2%5.0%0.6 $3.80
6/30/2021232,400 shares $987.70 thousand -18.1%5.8%0.6 $4.25
6/15/2021283,800 shares $1.25 million -19.8%7.1%0.4 $4.40
5/28/2021354,000 shares $1.67 million -6.4%8.9%0.1 $4.71

BNTC Short Interest - Frequently Asked Questions

Short interest is the volume of Benitec Biopharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 2,318,612 shares of BNTC short. 7.09% of Benitec Biopharma's shares are currently sold short. Learn More on Benitec Biopharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNTC shares currently have a short interest ratio of 21.5. Learn More on Benitec Biopharma's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.09% of Benitec Biopharma's floating shares are currently sold short.

Benitec Biopharma saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 2,318,612 shares, an increase of 2.3% from the previous total of 2,266,291 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

7.09% of Benitec Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Benitec Biopharma: Immunocore Holdings PLC Sponsored ADR (19.75%), Atai Beckley N.V. (8.50%), MBX Biosciences, Inc. (8.47%), Vir Biotechnology, Inc. (11.38%), Immatics N.V. (3.85%), KalVista Pharmaceuticals, Inc. (30.93%), Amylyx Pharmaceuticals, Inc. (15.18%), SELLAS Life Sciences Group, Inc. (31.34%), Urogen Pharma (15.59%), Phibro Animal Health Corporation (6.01%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling BNTC is an investing strategy that aims to generate trading profit from Benitec Biopharma as its price is falling. BNTC shares are trading up $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Benitec Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BNTC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNTC, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like BNTC:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:BNTC) was last updated on 5/27/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
The AI stocks about to become worthless (and one that isn't)
Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...
InvestorPlace | Sponsoredtc pixel